Click Here
1 known investors
Moonlight Therapeutics develops an intradermal stamp technology for treating food allergies, with its lead candidate MOON101 focused on peanut allergy treatment.
BiotechMedical Devices
1 known investors
Moonlight Therapeutics develops an intradermal stamp technology for treating food allergies, with its lead candidate MOON101 focused on peanut allergy treatment.